Table 2. Correlation between clinicopathologic data and miRNA-203 expression in Kazakh ESCCs.
| clinicopathological features | Cases |
 ± S |
T/F | P |
|---|---|---|---|---|
| gender | ||||
| Male | 49 | 0.249 ± 0.393 | 1.682 | 0.097 |
| Female | 45 | 0.180 ± 0.296 | ||
| Age (y) | ||||
| ≤Median (60y) | 51 | 0.288 ± 0.484 | 1.343 | 0.183 |
| >Median | 43 | 0.180 ± 0.227 | ||
| Histologic grade | ||||
| Well | 21 | 0.196 ± 0.267 | 0.574* | 0.565 |
| Moderate | 56 | 0.226 ± 0.379 | ||
| Poor | 17 | 0.130 ± 0.130 | ||
| Nodal status | ||||
| pN+ | 51 | 0.155 ± 0.343 | −1.720 | 0.089 |
| pN− | 43 | 0.275 ± 0.331 | ||
| TNM stage┼ | ||||
| I–II | 63 | 0.215 ± 0.293 | 0.186 | 0.852 |
| III–IV | 31 | 0.201 ± 0.427 | ||
*F value. ┼TNM stage: the clinicopathologic stage.